Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Prostate Cancer
77%
Prostate Cancer Risk
47%
Statins
22%
Radical Prostatectomy
21%
Androgen Deprivation Therapy
21%
Finland
20%
Statin Use
17%
Prostate Cancer Screening
15%
Antidiabetic Drugs
12%
Drug Use
11%
Three-dimensional (3D)
11%
Prostatectomy
10%
Atorvastatin
10%
Functional Outcome
10%
Castration-resistant Prostate Cancer
9%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
9%
Prostate-specific Antigen
9%
Cancer Mortality
9%
Prostate Cancer Patients
9%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
9%
National Cohort Study
9%
High-grade Prostate Cancer
9%
Hazard Ratio
8%
Prostate Cancer Survival
8%
Population-based Cohort Study
8%
Laparoscopic Prostatectomy
8%
Prostate Radiotherapy
8%
Confidence Interval
8%
Prostate
7%
Prostate Cancer Prognosis
7%
Population-based Cohort
7%
Expanded Prostate Cancer Index Composite
7%
Screening Trials
7%
Overall Survival
6%
Randomized Clinical Trial
6%
Metformin
6%
Prostate Cancer Progression
6%
Breast Cancer
6%
Antihypertensive Drugs
6%
Randomized Controlled Trial
6%
Cholesterol Levels
6%
EPIC-26
5%
Laparoscopic Radical Prostatectomy
5%
Polygenic Risk Score
5%
Visual Analog Scale
5%
Renal Cancer
5%
Antiepileptic Drugs
5%
Population-based Case-control Study
5%
Finnish Population
5%
Inguinal Hernia Repair
5%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Statin (Protein)
23%
Cancer Mortality
19%
Androgen
18%
Cohort Study
17%
Non-Steroidal Anti-Inflammatory Drug
15%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
14%
Cancer Survival
13%
Malignant Neoplasm
13%
Prostate Specific Antigen
13%
Cancer Prognosis
12%
Castration Resistant Prostate Cancer
12%
Breast Cancer
8%
Acetylsalicylic Acid
8%
Atorvastatin
7%
Antidiabetic Agent
7%
Cancer Incidence
7%
Neoplasm
7%
Androgen Receptor
6%
Antihypertensive Agent
6%
Anticonvulsive Agent
5%
Case-Control Study
5%
Bladder Cancer
5%
Comorbidity
5%
Biological Marker
5%
Medicine and Dentistry
Prostate Cancer
74%
Prostatectomy
30%
Androgen Deprivation Therapy
16%
Cancer Mortality
11%
Prostate Specific Antigen
10%
Neoplasm
9%
Cohort Analysis
9%
Antidiabetic Agent
9%
Randomized Controlled Trial
8%
Cancer Growth
7%
Urinary System
6%
Cancer Cell
6%
Androgen Receptor
6%
Castration Resistant Prostate Cancer
6%
Screening of Prostate Cancer
5%
Visual Analog Scale
5%
Hernioplasty
5%
Inguinal Hernia
5%
Personalized Medicine
5%
Clear Cell Renal Cell Carcinoma
5%
Malignant Neoplasm
5%
Continence
5%
Statin
5%
Cancer Therapy
5%
Incontinence
5%